Hem › Neuroblastom › Oregon
Kliniska studier för Neuroblastom i Oregon
6 studier för Neuroblastom söker deltagare vid platser i Oregon.
Städer i Oregon
Officiell studietext (engelska)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
RekryterarFas 3
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Oregon Health and Science University ( Site 1004), Portland
RekryterarFas 1/2
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Randall Children's Hospital, Portland
RekryterarFas 2
Upp till ålder 22 · Alla kön · Uppdaterad 4 sep. 2026 · NCT02559778Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Randall Children's Hospital, Portland
RekryterarFas 2
Ålder 1 till 21 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Legacy Emanuel Children's Hospital, Portland
RekryterarFas 3
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Randall Children's Hospital, Portland
RekryterarFas 2
12 Months – 21 Years · Alla kön · Uppdaterad 12 aug. 2026 · NCT05489887Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.